Viewing nowCombinationEmpagliflozin and Metformin Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 202501917 · Approved 2025.07.25 · Insurance code 645307250
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes when combined with dietary and exercise therapy through the co-administration of empagliflozin and metformin. Especially for patients whose blood sugar is not adequately controlled and who have cardiovascular disease, this medication may impact the occurrence of cardiovascular events, thus consulting professional guidelines is advised. This medication helps effectively improve blood sugar levels in patients.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, sections 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you forget to take this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, section 3. Patients Requiring Caution, subsection 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, section 2. Patients Who Must Not Use This Medicine, subsection 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used to lower blood sugar, and caution is needed as it can cause rare side effects such as severe lactic acidosis. When used with other diabetes medications, there can be a risk of hypoglycemia, so monitoring blood sugar status is essential. Patients with poor kidney function, acute kidney problems, severe infections, heart failure, and certain health conditions should not use this medication. It should be temporarily discontinued before and after tests that use iodinated contrast agents, and can only be resumed once kidney function has returned to normal. Women who are pregnant or nursing are advised not to use this medication. This drug can cause fluid loss, so patients at risk of dehydration should use it cautiously, as should the elderly and patients with cardiovascular diseases. Genital and urinary tract infections may occur during use, so if symptoms arise, consult a doctor immediately. Due to a potential drop in vitamin B12 levels, regular testing may be required during long-term use. In case of overdose, serious side effects such as lactic acidosis may occur, so dosage must be strictly followed, and medical attention should be sought immediately if side effects occur. Alcohol consumption should be avoided during treatment, and caution is necessary after sudden decreases in food intake or intense exercise due to the risk of hypoglycemia. The medication should be discontinued for a period before and after surgery, and resumed only after confirming kidney function is normal. This medication is not recommended for children under 18, and in elderly patients, starting at the minimum dosage while regularly monitoring kidney function is advisable. During treatment, consult a physician regarding possible interactions with other medications.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius.
Biconvex oval film-coated tablets with a light brownish-purple color
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.